{"d":{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Business(ID=20257511,Language='FR')","uri":"https://ws.parlament.ch/OData.svc/Business(ID=20257511,Language='FR')","type":"itsystems.Pd.DataServices.DataModel.Business"},"BusinessResponsibilities":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20257511,Language='FR')/BusinessResponsibilities"}},"RelatedBusinesses":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20257511,Language='FR')/RelatedBusinesses"}},"BusinessRoles":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20257511,Language='FR')/BusinessRoles"}},"Publications":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20257511,Language='FR')/Publications"}},"LegislativePeriods":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20257511,Language='FR')/LegislativePeriods"}},"Sessions":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20257511,Language='FR')/Sessions"}},"Preconsultations":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20257511,Language='FR')/Preconsultations"}},"Bills":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20257511,Language='FR')/Bills"}},"Councils":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20257511,Language='FR')/Councils"}},"BusinessTypes":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20257511,Language='FR')/BusinessTypes"}},"Votes":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20257511,Language='FR')/Votes"}},"SubjectsBusiness":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20257511,Language='FR')/SubjectsBusiness"}},"BusinessStates":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20257511,Language='FR')/BusinessStates"}},"Council":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20257511,Language='FR')/Council"}},"Transcripts":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20257511,Language='FR')/Transcripts"}},"ID":20257511,"Language":"FR","BusinessShortNumber":"25.7511","BusinessType":14,"BusinessTypeName":"Heure des questions. Question","BusinessTypeAbbreviation":"Qst.","Title":"Evolution inqui\u00e9tante autour des m\u00e9dicaments contenant de la cod\u00e9ine : Quelles mesures de pr\u00e9caution et de r\u00e9gulation sont-elles envisag\u00e9es ?","Description":null,"InitialSituation":null,"Proceedings":null,"DraftText":null,"SubmittedText":"<p>Depuis que les m\u00e9dicaments contentant de la cod\u00e9ine sont en cat\u00e9gorie de remise B, on constate une forte augmentation des quantit\u00e9s remises sur ordonnance \u00e0 des personnes d\u00e9pendantes ou qui pr\u00e9tendent l\u2019\u00eatre pour ensuite revendre ces produits sur le march\u00e9 noir.<br>- Comment le conseil f\u00e9d\u00e9ral explique-t-il cette \u00e9volution ?<br>- Quelles sont les mesures offertes par la LPTh et la LStup pour y r\u00e9pondre ?<br>- Quelles mesures au sens de l\u2019article 27 OAStup ont-elles d\u00e9j\u00e0 \u00e9t\u00e9 r\u00e9alis\u00e9es par l\u2019OFSP ?</p>","ReasonText":null,"DocumentationText":null,"MotionText":null,"FederalCouncilResponseText":"<span><p><span>Dans le cas de traitement de personnes d\u00e9pendantes, la prescription de stup\u00e9fiants est soumise \u00e0 autorisation cantonale, et ce de mani\u00e8re ind\u00e9pendante de la cat\u00e9gorie de remise du m\u00e9dicament. A l\u2019heure actuelle, le Conseil f\u00e9d\u00e9ral n\u2019a pas connaissance d\u2019une augmentation de prescriptions de m\u00e9dicaments contenant de la cod\u00e9ine \u00e0 des personnes d\u00e9pendantes.</span></p><p><span>&nbsp;</span></p><p><span>Selon la loi sur les produits th\u00e9rapeutiques, toute personne prescrivant ou remettant des m\u00e9dicaments est tenu \u00e0 un devoir de diligence. Celui-ci est accru dans le cas de la remise de stup\u00e9fiants, selon la loi sur les stup\u00e9fiants. Le contr\u00f4le de la remise et de la prescription de m\u00e9dicaments incombe aux cantons. Quiconque revend des m\u00e9dicaments sans satisfaire aux exigences de la loi sur les produits th\u00e9rapeutiques est passible de sanctions p\u00e9nales. </span></p><p><span>&nbsp;</span></p><p><span>Conform\u00e9ment \u00e0 la l\u00e9gislation applicable, l\u2019OFSP soutient les cantons et les communes dans le domaine de la r\u00e9duction des risques en encourageant notamment l\u2019\u00e9change de connaissances entre les sp\u00e9cialistes. S\u2019agissant de la cod\u00e9ine, il met par exemple des informations \u00e0 disposition des professionnels de la sant\u00e9 et promeut des bonnes pratiques.</span></p></span>","FederalCouncilProposal":null,"FederalCouncilProposalText":null,"FederalCouncilProposalDate":"\/Date(1750032000000)\/","SubmittedBy":"Crottaz Brigitte","BusinessStatus":229,"BusinessStatusText":"Liquid\u00e9","BusinessStatusDate":"\/Date(1750091273000)\/","ResponsibleDepartment":4,"ResponsibleDepartmentName":"D\u00e9partement de l'int\u00e9rieur","ResponsibleDepartmentAbbreviation":"DFI","IsLeadingDepartment":true,"Tags":"2841","Category":null,"Modified":"\/Date(1763088436267)\/","SubmissionDate":"\/Date(1749600000000)\/","SubmissionCouncil":1,"SubmissionCouncilName":"Conseil national","SubmissionCouncilAbbreviation":"CN","SubmissionSession":5209,"SubmissionLegislativePeriod":52,"FirstCouncil1":1,"FirstCouncil1Name":"Conseil national","FirstCouncil1Abbreviation":"CN","FirstCouncil2":null,"FirstCouncil2Name":null,"FirstCouncil2Abbreviation":null,"TagNames":"Sant\u00e9"}}